In order to participate in a live webinar or watch an on-demand webinar, you must be registered as a member of this website. If you already have an account, please log in. If not, you can create an account for free.
Register now Login
Mr. Miha Verdenik Cancel replyYou must be logged in to post a comment.
Los Angeles, USA
Thu., Nov. 27, 10:00
Mexico City, Mexico
Thu., Nov. 27, 12:00
New York, USA
Thu., Nov. 27, 13:00
London, UK
Thu., Nov. 27, 18:00
Berlin, Germany
Thu., Nov. 27, 19:00
Bucharest, Romania
Thu., Nov. 27, 20:00
Moscow, Russia
Thu., Nov. 27, 21:00
Abu Dhabi, UAE
Thu., Nov. 27, 22:00
New Delhi, India
Thu., Nov. 27, 23:30
Bangkok, Thailand
Fri., Nov. 28, 01:00
Beijing, China
Fri., Nov. 28, 02:00
Singapore
Fri., Nov. 28, 02:00
Tokyo, Japan
Fri., Nov. 28, 03:00
Sydney, Australia
Fri., Nov. 28, 05:00
Tribune Group GmbH Inc.
Nationally Approved PACE Program
Provider for FAGD/MAGD credit.
Approval does not imply acceptance by
any regulatory authority or AGD endorsement.
7/1/2024 - 6/30/2028.
Provider ID# 355051
English
German
French
Italian
Spanish
Thanks a lot for the great presentation
Thank you!
So you are comfortable with using an RB abutment on say a 5.5 implant?
Do U have any concerns on the abutment being too thin and weak when trying to do good biological contour
thank you
any word about indication, performance and study results regarding BLX an BLC?
tnx, Miha
how does the 15 degree abutment work inside a 7 degree morse
Great presentation! thank you.
thank you!
Do you also have outcome data on TLX implants?
Dr Walter, thank you for this great talk.
Were any of the results surprising? Will they change anything about how you practice or which patients you use TorcFit for?
Also, what factors could potentially compromise the performance of the TorcFit® connection despite the design advantages?
How would the treatment plan change if a patient requires a mix of implant lines but you want to maintain restorative consistency?
If you are comparing to the long term success of the BLT implant to the BLX/BLC there appears to be a decline in success rates. What are your thoughts on this?
What differences do you notice in the long term soft tissue response to other implant platforms?
Hi
Thank you for joining today’s webinar. If you have any questions for our experts about today’s presentation, please write them in this chat box and they will be addressed during the Q&A session.